ArticleBrain and behavior2026
Association of HDL-C Levels with Stroke and All-cause Mortality: A Prospective Cohort Study from the CHARLS.
Article in Brain and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundStroke has always been a huge medical challenge faced by China. Previous studies have found a negative correlation between high-density lipoprotein cholesterol (HDL-C) and stroke, but in recent years, with unsatisfactory drug experiments, researchers have begun to re-examine this relationship. Our research is based on the large population of middle-aged and elderly people in China, exploring the relationship between HDL-C and stroke and all-cause mortality.
methodsThe participants of this study were from the China Health and Retirement Longitudinal Study (CHARLS) database. We utilized univariate/multivariate logistic regression to screen the influencing factors of stroke. Using Cox regression, we calculated the hazard ratio (HR) for stroke and mortality, presenting our findings through Kaplan-Meier (KM) curves. We also presented the relationship between HDL-C and stroke and mortality by restricted cubic spline (RCS) regression analysis. A time-varying Cox analysis was conducted to evaluate the impact of changes in HDL-C on various outcomes. To strengthen the robustness and causal interpretation, we performed subgroup analysis, sensitivity analysis, and mediation pathway, and established a competing-risk model.
resultsHDL-C was negatively correlated with stroke. After adjusting for confounders, HDL-C remained a protective factor for stroke (HR 0.99, 95% CI 0.99-1.00, P < 0.05), especially in the male group, the normal BMI group, the group without dyslipidemia, and the group with hypertension in the subgroup analysis. However, no significant association was observed between HDL-C and all-cause mortality after adjustment (HR 1.00, 95% CI 1.00-1.01, p = 0.482). The results remained robust in sensitivity analysis and competitive risk models. The impact of HDL-C on the risk of stroke (HR 1.00, 95% CI 0.999-1.001, p = 0.887) and all-cause mortality (HR 1.00, 95% CI 0.9995-1.001, p = 0.539) did not show a significant trend over time. Mediation analysis revealed that BMI mediated 25% of the effect of HDL-C on stroke.
conclusionsIn Chinese people over 45 years old, HDL-C was a protective factor for stroke, while it had no significant association with all-cause mortality. BMI mediated the effect of HDL-C on stroke. This research highlights the critical role of HDL-C in stroke risk assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.